|
| | Publication Year | Title | Author(s) |
| 81 | 27-Oct-2020 | Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging. | Xia, Ying; Yassi, Nawaf; Raniga, Parnesh; Bourgeat, Pierrick; Desmond, Patricia; Doecke, James; Ames, David; Laws, Simon M; Fowler, Christopher; Rainey-Smith, Stephanie R; Martins, Ralph; Maruff, Paul; Villemagne, Victor L ; Masters, Colin L ; Rowe, Christopher C ; Fripp, Jurgen; Salvado, Olivier |
| 82 | 23-Oct-2020 | Reduced striatal vesicular monoamine transporter 2 in REM sleep behavior disorder: imaging prodromal parkinsonism. | Beauchamp, Leah C; Villemagne, Victor L ; Finkelstein, David I; Doré, Vincent ; Bush, Ashley I; Barnham, Kevin J; Rowe, Christopher C |
| 83 | 27-Sep-2020 | Severe Obstructive Sleep Apnea Is Associated with Higher Brain Amyloid Burden: A Preliminary PET Imaging Study. | Jackson, Melinda L ; Cavuoto, Marina; Schembri, Rachel M ; Doré, Vincent ; Villemagne, Victor L ; Barnes, Maree ; O'Donoghue, Fergal J ; Rowe, Christopher C ; Robinson, Stephen R |
| 84 | Aug-2020 | Exploiting the Full Potential of β-Amyloid and Tau PET Imaging for Drug Efficacy Testing. | Barthel, Henryk; Seibyl, John; Lammertsma, Adriaan A; Villemagne, Victor L ; Sabri, Osama |
| 85 | 12-Jun-2020 | Human biodistribution and internal dosimetry of 4-[ 18F]fluorobenzyl-dexetimide: a PET radiopharmaceutical for imaging muscarinic acetylcholine receptors in the brain and heart. | Pain, Cameron D; O'Keefe, Graeme J; Ackermann, Uwe ; Dore, Vincent; Villemagne, Victor L ; Rowe, Christopher C |
| 86 | 9-Jun-2020 | Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer's disease pathology. | Ashraf, Azhaar; Ashton, Nicholas J; Chatterjee, Pratishtha; Goozee, Kathryn; Shen, Kaikai; Fripp, Jurgen; Ames, David; Rowe, Christopher C ; Masters, Colin L ; Villemagne, Victor L ; Hye, Abdul; Martins, Ralph N; So, Po-Wah |
| 87 | 6-Jun-2020 | Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease. | Schultz, Stephanie A; Strain, Jeremy F; Adedokun, Adedamola; Wang, Qing; Preische, Oliver; Kuhle, Jens; Flores, Shaney; Keefe, Sarah; Dincer, Aylin; Ances, Beau M; Berman, Sarah B; Brickman, Adam M; Cash, David M; Chhatwal, Jasmeer; Cruchaga, Carlos; Ewers, Michael; Fox, Nick N; Ghetti, Bernardino; Goate, Alison; Graff-Radford, Neill R; Hassenstab, Jason J; Hornbeck, Russ; Jack, Clifford; Johnson, Keith; Joseph-Mathurin, Nelly; Karch, Celeste M; Koeppe, Robert A; Lee, Athene K W; Levin, Johannes; Masters, Colin; McDade, Eric; Perrin, Richard J; Rowe, Christopher C ; Salloway, Stephen; Saykin, Andrew J; Sperling, Reisa; Su, Yi; Villemagne, Victor L ; Vöglein, Jonathan; Weiner, Michael; Xiong, Chengjie; Fagan, Anne M; Morris, John C; Bateman, Randall J; Benzinger, Tammie L S; Jucker, Mathias; Gordon, Brian A |
| 88 | 15-May-2020 | Exploiting the Full Potential of Beta-Amyloid and Tau PET Imaging for Drug Efficacy Testing. | Barthel, Henryk; Seibyl, John; Lammertsma, Adriaan A; Villemagne, Victor L ; Sabri, Osama |
| 89 | May-2020 | Effect of a 24-month physical activity program on brain changes in older adults at risk of Alzheimer's disease: the AIBL active trial. | Venkatraman, Vijay K; Sanderson, Andrew; Cox, Kay L; Ellis, Kathryn A; Steward, Christopher; Phal, Pramit M; Gorelik, Alexandra; Sharman, Matthew J; Villemagne, Victor L ; Lai, Michelle; Cyarto, Elizabeth V; Merkel, Bernd; Ames, David; Szoeke, Cassandra; Rowe, Christopher C ; Masters, Colin L ; Lautenschlager, Nicola T; Desmond, Patricia M |
| 90 | 29-Apr-2020 | Baseline White Matter Is Associated With Physical Fitness Change in Preclinical Alzheimer's Disease. | Venkatraman, Vijay K; Steward, Christopher E; Cox, Kay L; Ellis, Kathryn A; Phal, Pramit M; Sharman, Matthew J; Villemagne, Victor L ; Lai, Michelle M Y; Cyarto, Elizabeth V; Ames, David; Szoeke, Cassandra; Rowe, Christopher C ; Masters, Colin L ; Lautenschlager, Nicola T; Desmond, Patricia M |
| 11 | Apr-2020 | Longitudinal evaluation of the natural history of amyloid-β in plasma and brain. | Burnham, Samantha C; Fandos, Noelia; Fowler, Christopher; Pérez-Grijalba, Virginia; Doré, Vincent ; Doecke, James D; Shishegar, Rosita; Cox, Timothy; Fripp, Jurgen; Rowe, Christopher C ; Sarasa, Manuel; Masters, Colin L ; Pesini, Pedro; Villemagne, Victor L |
| 12 | Apr-2020 | [¹⁸F]THK5351 PET Imaging in Patients with Mild Cognitive Impairment. | Jeong, Hye Jin; Lee, Hyon; Lee, Sang Yoon; Seo, Seongho; Park, Kee Hyung; Lee, Yeong Bae; Shin, Dong Jin; Kang, Jae Myeong; Yeon, Byeong Kil; Kang, Seung Gul; Cho, Jaelim; Seong, Joon Kyung; Okamura, Nobuyuki; Villemagne, Victor L ; Na, Duk L; Noh, Young |
| 13 | 31-Mar-2020 | Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging. | Doecke, James D; Ward, Larry; Burnham, Samantha C; Villemagne, Victor L ; Li, Qiao-Xin; Collins, Steven; Fowler, Christopher J; Manuilova, Ekaterina; Widmann, Monika; Rainey-Smith, Stephanie R; Martins, Ralph N; Masters, Colin L |
| 14 | 4-Mar-2020 | Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease. | Amadoru, Sanka ; Doré, Vincent ; McLean, Catriona A; Hinton, Fairlie; Shepherd, Claire E; Halliday, Glenda M; Leyton, Cristian E; Yates, Paul A ; Hodges, John R; Masters, Colin L ; Villemagne, Victor L ; Rowe, Christopher C |
| 15 | Mar-2020 | Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD. | Papp, Kathryn V; Buckley, Rachel; Mormino, Elizabeth; Maruff, Paul; Villemagne, Victor L ; Masters, Colin L ; Johnson, Keith A; Rentz, Dorene M; Sperling, Reisa A; Amariglio, Rebecca E |
| 16 | 27-Feb-2020 | Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease. | Dhiman, Kunal; Gupta, Veer Bala; Villemagne, Victor L ; Eratne, Dhamidhu; Graham, Petra L; Fowler, Christopher; Bourgeat, Pierrick; Li, Qiao-Xin; Collins, Steven; Bush, Ashley I; Rowe, Christopher C ; Masters, Colin L ; Ames, David; Hone, Eugene; Blennow, Kaj; Zetterberg, Henrik; Martins, Ralph N |
| 17 | Feb-2020 | Increased cerebral blood flow with increased amyloid burden in the preclinical phase of alzheimer's disease. | Fazlollahi, Amir; Calamante, Fernando; Liang, Xiaoyun; Bourgeat, Pierrick; Raniga, Parnesh; Doré, Vincent ; Fripp, Jurgen; Ames, David; Masters, Colin L ; Rowe, Christopher C ; Connelly, Alan; Villemagne, Victor L ; Salvado, Olivier |
| 18 | 2020 | Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance. | Pedrini, Steve; Hone, Eugene; Gupta, Veer B; James, Ian; Teimouri, Elham; Bush, Ashley I; Rowe, Christopher C ; Villemagne, Victor L ; Ames, David; Masters, Colin L ; Rainey-Smith, Stephanie; Verdile, Giuseppe; Sohrabi, Hamid R; Raida, Manfred R; Wenk, Markus R; Taddei, Kevin; Chatterjee, Pratishtha; Martins, Ian; Laws, Simon M; Martins, Ralph N |
| 19 | 2020 | Can amyloid PET differentiate "pure" LBD from AD with or without LBD copathology? | Landau, Susan M; Villemagne, Victor L |
| 20 | 2020 | Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's Disease. | Lim, Yen Ying; Maruff, Paul; Kaneko, Naoki; Doecke, James; Fowler, Christopher; Villemagne, Victor L ; Kato, Takashi; Rowe, Christopher C ; Arahata, Yutaka; Iwamoto, Shinichi; Ito, Kengo; Tanaka, Koichi; Yanagisawa, Katsuhiko; Masters, Colin L ; Nakamura, Akinori |
Loading...
2
0
20
0
false
0000-0002-5832-9875